Community-Based Health Program for Healthy Aging
(EMBOLDEN Trial)
Trial Summary
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the idea that Community-Based Health Program for Healthy Aging is an effective treatment?
The available research shows that the Community-Based Health Program for Healthy Aging, also known as the EMBOLDEN Program, is designed to improve mobility and health in older adults. It focuses on physical activity, nutrition, social participation, and helping people navigate community systems. While the specific data on its effectiveness isn't detailed in the provided information, similar community-based programs have shown benefits. For example, the Lifestyle Interventions and Independence for Elders (LIFE) trial reduced mobility issues by up to 28% in older adults. This suggests that community-based programs like EMBOLDEN could also be effective in improving mobility and health in older adults.12345
What safety data exists for the Community-Based Health Program for Healthy Aging?
The provided research does not directly address safety data for the Community-Based Health Program for Healthy Aging or its related interventions like the EMBOLDEN Program. The studies focus on program design, implementation, and effectiveness, but do not specifically report on safety outcomes. Further investigation into specific safety evaluations or trials would be needed to provide a comprehensive answer.12367
Is the 3-month community-based mobility and health intervention a promising treatment for healthy aging?
Yes, the 3-month community-based mobility and health intervention, also known as the EMBOLDEN Program, is promising for healthy aging. It helps older adults improve their physical activity, nutrition, social participation, and ability to navigate health systems, especially for those facing barriers in accessing community programs. Community-based approaches like this have shown improvements in health behaviors and access to health services, making them effective for promoting health and preventing disease.12368
What is the purpose of this trial?
Physical mobility and social participation are needed to maintain independence and quality of life for adults over 55 years of age. Despite the known benefits of physical activity and dietary change programs for older adults, the best ways to deliver these interventions are not well understood. The goal of the EMBOLDEN study is to promote physical and community mobility in older adults who experience difficulties taking up community programs and reside in areas of high health inequity. Building on existing best practices, the investigators will implement and evaluate an innovative co-designed community-based program to promote physical activity, healthy eating, social participation, and system navigation. The potential for spreading this program throughout Hamilton and adapted to other Canadian communities will also be explored
Research Team
Rebecca Ganann, PhD
Principal Investigator
McMaster University
Eligibility Criteria
This trial is for community-dwelling adults aged 55 and older who live in specific neighborhoods chosen for the study. It aims to help those with limited mobility or health disparities improve their quality of life through a program that encourages physical activity, healthy eating, and social involvement.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a 3-month community-based mobility and healthy aging intervention, including weekly interactive group-based health education sessions and tailored system navigation support.
Follow-up
Participants are monitored for changes in physical activity, quality of life, and other health metrics to assess the maintenance of intervention effects.
Treatment Details
Interventions
- 3 month community-based mobility and health intervention
3 month community-based mobility and health intervention is already approved in Canada for the following indications:
- Promoting physical activity, healthy eating, social participation, and system navigation in older adults
Find a Clinic Near You
Who Is Running the Clinical Trial?
McMaster University
Lead Sponsor
The Labarge Centre for Mobility in Aging
Collaborator
Canadian Institutes of Health Research (CIHR)
Collaborator
Public Health Agency of Canada (PHAC)
Collaborator